Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in SLN — Silence Therapeutics plc

CIK 1214717 BOSTON, MA

Position in SLN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$324,327
+$168,662 QoQ
Shares Held
29,538
0.0% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 72 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,515,789 across 520 Biotechnology names. SLN ranks #380 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SLN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $324,327 29,538
2026-03-31 $155,665 29,538
2025-12-31 $179,591 29,538
2025-09-30 $153,302 29,538
2025-06-30 $171,320 29,538
2025-03-31 $82,955 29,417
2024-12-31 $202,388 29,417
2024-09-30 $534,801 29,417
2024-06-30 $558,923 29,417
2024-03-31 $484,423 22,427
2023-12-31 $389,556 22,427
2023-09-30 $209,401 21,324
2023-06-30 $94,638 17,207
2023-03-31 $91,059 14,687
2022-12-31 $200,949 13,177
2022-09-30 $132,231 13,177